These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28885426)

  • 41. Feasibility of prophylactic salpingectomy during vaginal hysterectomy.
    Antosh DD; High R; Brown HW; Oliphant SS; Abed H; Philip N; Grimes CL
    Am J Obstet Gynecol; 2017 Nov; 217(5):605.e1-605.e5. PubMed ID: 28734829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review.
    Kahn RM; Gordhandas S; Godwin K; Stone RL; Worley MJ; Lu KH; Long Roche KC
    JAMA Surg; 2023 Nov; 158(11):1204-1211. PubMed ID: 37672283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylactic salpingectomy and prophylactic salpingoophorectomy for adnexal high-grade serous epithelial carcinoma: A reappraisal.
    Oliver Perez MR; Magriñá J; García AT; Jiménez Lopez JS
    Surg Oncol; 2015 Dec; 24(4):335-44. PubMed ID: 26690823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salpingectomy and Ovarian Cancer Prevention.
    Harris AL
    Nurs Womens Health; 2015 Dec-2016 Jan; 19(6):543-9. PubMed ID: 26682662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy.
    Kwon JS; McAlpine JN; Hanley GE; Finlayson SJ; Cohen T; Miller DM; Gilks CB; Huntsman DG
    Obstet Gynecol; 2015 Feb; 125(2):338-345. PubMed ID: 25568991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The fallopian tube: from back stage to center stage.
    Greene MH; Mai PL
    Cancer Prev Res (Phila); 2015 May; 8(5):339-41. PubMed ID: 25802341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.
    Pérez-López FR; Ceausu I; Depypere H; Kehoe S; Lambrinoudaki I; Mueck A; Senturk LM; Simoncini T; Stevenson JC; Stute P; Rees M
    Maturitas; 2017 Jun; 100():86-91. PubMed ID: 28389043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opportunistic salpingectomy for ovarian cancer prevention.
    Hanley GE; McAlpine JN; Kwon JS; Mitchell G
    Gynecol Oncol Res Pract; 2015; 2():5. PubMed ID: 27231565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology.
    Mikami M; Nagase S; Yamagami W; Ushijma K; Tashiro H; Katabuchi H;
    J Gynecol Oncol; 2017 Jul; 28(4):e52. PubMed ID: 28541639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Call to lower threshold for pre-emptive surgery.
    Nurs Stand; 2016 Jul; 30(47):17. PubMed ID: 27440339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary prevention of ovarian cancer: a patient decision aid for opportunistic salpingectomy.
    van Lieshout LAM; Gelderblom ME; de Hullu JA; The R; van Ginkel AA; Oerlemans AJM; Smeets KMWH; Schreurs MPH; Piek JMJ; Hermens RPMG
    Am J Obstet Gynecol; 2022 Feb; 226(2):234.e1-234.e14. PubMed ID: 34536392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trends of Opportunistic Salpingectomy.
    Ding DC; Huang C; Chu TY; Wei YC; Chen PC; Hong MK
    JSLS; 2018; 22(3):. PubMed ID: 30275673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Salpingectomy and the Risk of Ovarian Cancer in Ontario.
    Giannakeas V; Murji A; Lipscombe LL; Narod SA; Kotsopoulos J
    JAMA Netw Open; 2023 Aug; 6(8):e2327198. PubMed ID: 37566421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rationale for opportunistic salpingectomy during gynecological surgery for a benign condition: A review of the available literature.
    Buffeteau A; Tanguy Le Gac Y; Weyl A; Chantalat E; Guerby P; Vidal F
    J Gynecol Obstet Hum Reprod; 2020 Oct; 49(8):101829. PubMed ID: 32534217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ovarian cancer risk after salpingectomy: a nationwide population-based study.
    Falconer H; Yin L; Grönberg H; Altman D
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25628372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bridging different realities - a qualitative study on patients' experiences of preoperative care for benign hysterectomy and opportunistic salpingectomy in Sweden.
    Collins E; Lindqvist M; Mogren I; Idahl A
    BMC Womens Health; 2020 Sep; 20(1):198. PubMed ID: 32917194
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ovarian cancer risk reduction through opportunistic salpingectomy.
    Kwon JS
    J Gynecol Oncol; 2015 Apr; 26(2):83-6. PubMed ID: 25872888
    [No Abstract]   [Full Text] [Related]  

  • 58. [Feasibility of opportunistic salpingectomy at the time of vaginal hysterectomy for benign pathology and evaluation of occult tubal lesions prevalence: Preliminary study].
    Chene G; Meysonnier C; Buenerd A; Moret S; Nadaud B; Beaufils E; Le Bail-Carval K; Chabert P; Mellier G; Lamblin G
    J Gynecol Obstet Biol Reprod (Paris); 2016 Jun; 45(6):549-58. PubMed ID: 26321613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ovarian Cancer Prevention and Screening.
    Menon U; Karpinskyj C; Gentry-Maharaj A
    Obstet Gynecol; 2018 May; 131(5):909-927. PubMed ID: 29630008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opportunistic salpingectomy to decrease the mortality from ovarian cancer: Can we expand the pool of eligible patients?
    Bakkum-Gamez JN; Cliby WA
    Surgery; 2018 Nov; 164(5):935-936. PubMed ID: 29945782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.